Artwork

Content provided by ARUP Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARUP Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

A Sensible Approach to LDT Regulation

28:24
 
Share
 

Manage episode 335531702 series 2396871
Content provided by ARUP Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARUP Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The VALID Act currently being debated in Congress would increase the regulatory burden on clinical laboratories. In this interview, Dr. David Grenache from TriCore Laboratories and the University of New Mexico, together with Dr. Vince Stine from the American Association for Clinical Chemistry, explain why VALID would slow down innovation while it raises costs, and why VALID appears to be designed to benefit a particular industry sector rather than patients.
  continue reading

81 episodes

Artwork

A Sensible Approach to LDT Regulation

LabMind

22 subscribers

published

iconShare
 
Manage episode 335531702 series 2396871
Content provided by ARUP Laboratories. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by ARUP Laboratories or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The VALID Act currently being debated in Congress would increase the regulatory burden on clinical laboratories. In this interview, Dr. David Grenache from TriCore Laboratories and the University of New Mexico, together with Dr. Vince Stine from the American Association for Clinical Chemistry, explain why VALID would slow down innovation while it raises costs, and why VALID appears to be designed to benefit a particular industry sector rather than patients.
  continue reading

81 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide